Japanese Multicenter Clinical Trial of Intravenous Polyethylene Glycol-Treated Immunoglobulin and Comparison With Previous Clinical Trial of Sulfonated Immunoglobulin in Guillain-Barré Syndrome

Clinical and Experimental Neuroimmunology - United Kingdom
doi 10.1111/cen3.12407
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Immunoglobulin G Fc N-Glycosylation in Guillain-Barré Syndrome Treated With Intravenous Immunoglobulin

Clinical and Experimental Immunology
AllergyImmunology
2014English

Plasmapheresis Treatment in Guillain-Barré Syndrome: Potential Benefit Over Intravenous Immunoglobulin

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2010English

Uses of Intravenous Immunoglobulin: A 13-Year Evaluation of Guillain–Barré Syndrome in Fez, Morocco

Journal of Biology and Medicine
2017English

Cost-Effectiveness Analysis of 10% Intravenous Immunoglobulin Compared With Plasma Exchange in Treatment of Children With Guillain–Barré Syndrome in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Is a Second Cycle of Immunoglobulin Justified in Axonal Forms of Guillain-Barré Syndrome?

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2015English

Clinical and Electrophysiological Features of Post-Traumatic Guillain-Barré Syndrome

BMC Neurology
MedicineNeurology
2017English

Intravenous Immunoglobulin as Clinical Immune-Modulating Therapy

CMAJ
Medicine
2015English

Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients With COVID-19: A Multicenter Retrospective Cohort Study

2020English

Guillain-Barré Syndrome

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy